Cargando…
Exposure to Propylthiouracil in the First Trimester of Pregnancy and Birth Defects: A Study at a Single Institution
CONTEXT: Medical treatment of Graves disease during the first trimester has been the subject of controversy ever since treatment with an antithyroid drug during the first trimester was reported to possibly be associated with an increased risk of birth defects in newborns. OBJECTIVE: We investigated...
Autores principales: | Yoshihara, Ai, Noh, Jaeduk Yoshimura, Watanabe, Natsuko, Fukushita, Miho, Matsumoto, Masako, Suzuki, Nami, Hoshiyama, Ayako, Suzuki, Ai, Mitsumatsu, Takako, Kinoshita, Aya, Mikura, Kentaro, Yoshimura, Ran, Sugino, Kiminori, Ito, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814387/ https://www.ncbi.nlm.nih.gov/pubmed/33506163 http://dx.doi.org/10.1210/jendso/bvaa204 |
Ejemplares similares
-
The Potential Impact of the COVID-19 Pandemic on Clinical Management of Thyroid Disorders in Japan
por: Inoue, Kosuke, et al.
Publicado: (2021) -
Clinical Course of Euthyroid Subjects With Positive TSH Receptor Antibody: How Often Does Graves’ Disease Develop?
por: Suzuki, Nami, et al.
Publicado: (2021) -
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 Pandemic
por: Inoue, Kosuke, et al.
Publicado: (2021) -
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
por: Suzuki, Nami, et al.
Publicado: (2018) -
Outpatient (131)I Treatment for a Patient with Graves' Disease Receiving Hemodialysis
por: Suzuki, Miho, et al.
Publicado: (2016)